ASIA PACIFIC VETERINARY MEDICINES MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC VETERINARY MEDICINES MARKET FORECAST 2019-2028

ASIA PACIFIC VETERINARY MEDICINES MARKET FORECAST 2019-2028

The Asia Pacific veterinary medicines market is evaluated to record a CAGR of 5.85%, during the forecast years of 2019 to 2028. The key drivers propelling the market growth include high investments in research and development by international players, and the imperative need to control the high prevalence rate of zoonotic complications, and disease outbreaks.

ASIA PACIFIC VETERINARY MEDICINES MARKET FORECAST 2019-2028

Asia Pacific Veterinary Medicines Market by Animal Type (Companion Animals, Livestock Animals) by Distribution Channel (Retail Veterinary Pharmacies, Veterinary Hospital Pharmacies) by Route of Administration (Parenteral Route, Oral Route, Topical Route) by Product (Drugs (Anti-infective, Anti-inflammatory, Parasiticide), Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines), Medicated Feed Additives(Antibiotics, Amino Acids)) and by Geography.

Request free sample

The Asia Pacific veterinary medicines market is evaluated to record a CAGR of 5.85%, during the forecast years of 2019 to 2028. The key drivers propelling the market growth include high investments in research and development by international players, and the imperative need to control the high prevalence rate of zoonotic complications, and disease outbreaks.
Asia Pacific Veterinary Medicines Market

To learn more about this report, request a free sample copy

The Asia Pacific veterinary medicines market growth is assessed by analyzing China, Japan, Vietnam, Thailand, Australia & New Zealand, South Korea, India, Indonesia, and the rest of the Asia Pacific. According to a statistics, in 2018, there were nearly 33.9 million dog owners and 22.6 million cat owners in China. Accordingly, an alarming increase in the incidence of numerous infectious diseases affecting companion animals, such as canine parvovirus and canine distemper, primarily drives the market growth.

Moreover, growing awareness among people, concerning the early diagnosis and treatment in companion animals, as well as, the increasing disposable income, has generated a surge in the country’s animal healthcare expenditure. For instance, disposable income increased by nearly 600% for rural and urban households, from 2000 to 2018. China is also observing increased pet ownership, as well as the rising awareness linked with prompt diagnosis and treatment of diseases that are common among companion animals. Thus, such factors are anticipated to propel market growth.

Hester Biosciences, headquartered in India, is primarily involved in achieving better health among animals, across all species, in addition to preventing and monitoring animal diseases. The company also manufactures and trades animal health products and poultry vaccines. In June 2017, it acquired a controlling stake in Texas Lifesciences, and secured a Loan M license for 23 veterinary pharmaceutical products.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • SURGING LIVESTOCK POPULATION
      • INCREASING ANIMAL HEALTHCARE EXPENDITURE
      • GROWING PET OWNERSHIP
      • RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
    •    KEY RESTRAINTS
      • STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
      • SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      • HIGH COST OF VACCINATIONS
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ANIMAL TYPE
    • COMPANION ANIMALS
    • LIVESTOCK ANIMALS
  3. MARKET BY DISTRIBUTION CHANNEL
    • RETAIL VETERINARY PHARMACIES
    • VETERINARY HOSPITAL PHARMACIES
  4. MARKET BY ROUTE OF ADMINISTRATION
    • PARENTERAL ROUTE
    • ORAL ROUTE
    • TOPICAL ROUTE
  5. MARKET BY PRODUCT
    • DRUGS
    • VACCINES
    • MEDICATED FEED ADDITIVES
  6. GEOGRAPHICAL ANALYSIS
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • AUSTRALIA & NEW ZEALAND
      • INDIA
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
  1. COMPANY PROFILES
    • ARCHER DANIELS MIDLAND
    • BIOGENESIS BAGO SA
    • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    • CEVA SANTE ANIMALE
    • DECHRA PHARMACEUTICALS PLC
    • ELANCO
    • EVONIK INDUSTRIES AG (RAG STIFTUNG)
    • HESTER BIOSCIENCES LIMITED
    • INDIAN IMMUNOLOGICALS LIMITED
    • KINDRED BIOSCIENCES
    • MERCK & CO
    • NEOGEN CORPORATION
    • VETOQUINOL (SOPARFIN SCA)
    • VIRBAC SA
    • ZOETIS

TABLE LIST

TABLE 1: MARKET SNAPSHOT – VETERINARY MEDICINES

TABLE 2: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 10: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURES LIST 

FIGURE 1: LIVESTOCK SPECIES POPULATION IN INDIA, 2019, (MILLION)

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019

FIGURE 7: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 8: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 9: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 10: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 11: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 12: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 13: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 14: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 15: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 16: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019

FIGURE 17: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)

FIGURE 18: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 19: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)

FIGURE 20: ASIA PACIFIC VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 21: CHINA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 22: JAPAN VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: INDIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: SOUTH KOREA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 26: THAILAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 27: INDONESIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: VIETNAM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 29: REST OF ASIA PACIFIC VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • AUSTRALIA & NEW ZEALAND
      • INDIA
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
  1. MARKET BY ANIMAL TYPE
    • COMPANION ANIMALS
    • LIVESTOCK ANIMALS
  2. MARKET BY DISTRIBUTION CHANNEL
    • RETAIL VETERINARY PHARMACIES
    • VETERINARY HOSPITAL PHARMACIES
  3. MARKET BY ROUTE OF ADMINISTRATION
    • PARENTERAL ROUTE
    • ORAL ROUTE
    • TOPICAL ROUTE
  4. MARKET BY PRODUCT
    • DRUGS
    • VACCINES
    • MEDICATED FEED ADDITIVES

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now